- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
该股处于空头行情中，可能有短期反弹。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有35家主力机构披露2026-06-30报告期持股数据，持仓量总计2.74亿股，占流通A股43.46%
- 波段诊断：
-
技术面诊股
诊断结果：4.4技术面打败了36%的股票
技术面评分前10的股票
近期的平均成本为5.65元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为5.65元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"5.65","date":1789028263,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2026.09.11","stock":"-1.91","trade":null,"ind":"-1.08"},{"date":"2026.09.10","stock":"-1.71","trade":null,"ind":"-0.77"},{"date":"2026.09.09","stock":"-2.01","trade":null,"ind":"0.15"},{"date":"2026.09.08","stock":"1.70","trade":null,"ind":"-0.52"},{"date":"2026.09.07","stock":"-0.51","trade":null,"ind":"1.91"},{"date":"2026.09.04","stock":"-0.84","trade":null,"ind":"-0.79"},{"date":"2026.09.03","stock":"-1.98","trade":null,"ind":"0.10"},{"date":"2026.09.02","stock":"-1.14","trade":null,"ind":"-1.88"},{"date":"2026.09.01","stock":"3.72","trade":null,"ind":"-1.02"},{"date":"2026.08.31","stock":"-2.15","trade":null,"ind":"0.44"},{"date":"2026.08.28","stock":"-1.14","trade":null,"ind":"-0.68"},{"date":"2026.08.27","stock":"0.33","trade":null,"ind":"1.50"},{"date":"2026.08.26","stock":"-0.81","trade":null,"ind":"0.69"},{"date":"2026.08.25","stock":"3.02","trade":null,"ind":"-0.35"},{"date":"2026.08.24","stock":"-3.40","trade":null,"ind":"-2.13"},{"date":"2026.08.21","stock":"-1.75","trade":null,"ind":"0.87"},{"date":"2026.08.20","stock":"4.83","trade":null,"ind":"0.59"},{"date":"2026.08.19","stock":"-0.17","trade":null,"ind":"-5.01"},{"date":"2026.08.18","stock":"-2.28","trade":null,"ind":"-0.56"},{"date":"2026.08.17","stock":"-4.06","trade":null,"ind":"2.44"},{"date":"2026.08.14","stock":"2.23","trade":null,"ind":"0.45"}]
凯普生物,深证成指,医疗器械指数
压力支撑
该股压力位为5.66元，支撑位为5.57元。
[{"text":"\u538b\u529b\u4f4d","value":"5.66","date":1789056000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"5.57","date":1789056000,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.9资金面打败了27%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：09月11日 20:30
| 机构今日流向(万元) | -771.82 | 机构5日流向(万元) | -1942.52 |
| 机构10日流向(万元) | -3556.82 | 机构20日流向(万元) | -7563.06 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少1565.43万股，其中基金净增仓8家，主力净减仓58家，暂未发现中长期投资价值。
截止2026-06-30，共35家主力机构（基金30家，一般法人5家），持仓量总计27389.27万股，占流通A股43.46%
其中，基金持仓与2025-12-31相比：
增仓：14家 ，增持 127.81万股
减仓：6家 ，减持 14.24万股
新出现在主力名单中：10家 ，持有1092.5万股
从主力名单中消失：68家 ，原持有694.06万股
其中，基金持仓与2025-12-31相比：
增仓：14家 ，增持 127.81万股
减仓：6家 ，减持 14.24万股
新出现在主力名单中：10家 ，持有1092.5万股
从主力名单中消失：68家 ，原持有694.06万股
消息面诊股
诊断结果：5.8消息面打败了34%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 凯普生物：9月10日获融资买入351.89万元
2026-09-11 - 凯普生物：9月9日获融资买入458.60万元
2026-09-10 - 凯普生物：9月8日获融资买入665.05万元
2026-09-09 - 凯普生物：9月7日获融资买入358.89万元
2026-09-08 - 医疗器械上市公司毛利率排行来了（附名单）
2026-09-07 - 凯普生物：9月4日获融资买入365.22万元
2026-09-07 - 凯普生物（截止2026年8月31日）股东人数为34
2026-09-04 - 凯普生物：9月3日获融资买入793.44万元
2026-09-04 - 凯普生物：9月2日获融资买入526.23万元
2026-09-03 - 凯普生物：9月1日获融资买入792.45万元
2026-09-02
消息列表
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-15 |
| 一般消息 | 募资投向 | 2026-08-14 | |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2026-06-30 |
| 一般消息 | 高管变动 | 因个人原因 | 2026-06-10 |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-29 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-04-29 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-04-18 |
| 利好 | 业绩预告 | 预计减亏 | 2026-01-28 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-12-06 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了3%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2026.09.11","price":"-1.08","value":null},{"date":"2026.09.10","price":"-0.77","value":null},{"date":"2026.09.09","price":"0.15","value":null},{"date":"2026.09.08","price":"-0.52","value":null},{"date":"2026.09.07","price":"1.91","value":null},{"date":"2026.09.04","price":"-0.79","value":null},{"date":"2026.09.03","price":"0.10","value":null},{"date":"2026.09.02","price":"-1.88","value":null},{"date":"2026.09.01","price":"-1.02","value":null},{"date":"2026.08.31","price":"0.44","value":null},{"date":"2026.08.28","price":"-0.68","value":null},{"date":"2026.08.27","price":"1.50","value":null},{"date":"2026.08.26","price":"0.69","value":null},{"date":"2026.08.25","price":"-0.35","value":null},{"date":"2026.08.24","price":"-2.13","value":null},{"date":"2026.08.21","price":"0.87","value":null},{"date":"2026.08.20","price":"0.59","value":null},{"date":"2026.08.19","price":"-5.01","value":null},{"date":"2026.08.18","price":"-0.56","value":null},{"date":"2026.08.17","price":"2.44","value":null},{"date":"2026.08.14","price":"0.45","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 采纳股份 | 29.48% | -0.07% | 5.2分 |
| 2 | 浩欧博 | 27.29% | 13.49% | 6.1分 |
| 3 | 南卫股份 | 20.90% | 0.52% | 4.9分 |
| 4 | 透景生命 | 18.20% | -6.24% | 4.2分 |
| 5 | 洁特生物 | 16.60% | 2.71% | 5.8分 |
| 6 | 英科医疗 | 14.70% | 1.38% | 5.3分 |
| 8 | 五洲医疗 | 9.90% | -6.92% | 4.2分 |
| 10 | 迈瑞医疗 | 9.11% | -3.47% | 5.4分 |
| 12 | 海尔生物 | 6.87% | 0.06% | 5.5分 |
| 14 | 康为世纪 | 6.54% | -3.00% | 5.0分 |
| 16 | 可孚医疗 | 5.22% | 1.74% | 5.7分 |
| 18 | 健尔康 | 2.15% | -0.67% | 5.1分 |
| 20 | - | 0.34% | -6.20% | 分 |
| 22 | 黄山胶囊 | 0.15% | -2.38% | 4.9分 |
| 24 | ST凯利 | -0.16% | -2.53% | 5.0分 |
| 26 | 科华生物 | -0.35% | -1.22% | 5.2分 |
| 28 | *ST益通 | -0.64% | 0.65% | 4.6分 |
| 30 | - | -1.04% | -5.91% | 分 |
| 32 | 爱迪特 | -1.69% | -0.66% | 5.5分 |
| 34 | 鱼跃医疗 | -2.61% | -1.71% | 5.2分 |
| 36 | 山东药玻 | -2.93% | -2.93% | 4.9分 |
| 38 | 科美诊断 | -3.14% | -2.37% | 5.1分 |
| 40 | 基蛋生物 | -3.19% | -1.94% | 5.9分 |
| 42 | 康德莱 | -3.66% | -2.64% | 5.0分 |
| 44 | 正海生物 | -3.91% | -1.34% | 4.7分 |
| 46 | - | -4.13% | -2.52% | 分 |
| 48 | - | -4.65% | -5.67% | 分 |
| 50 | 联影医疗 | -4.77% | -4.92% | 5.5分 |
| 52 | 威高骨科 | -4.84% | -3.35% | 5.3分 |
| 54 | 利德曼 | -5.18% | -3.57% | 4.1分 |
| 56 | 安旭生物 | -5.32% | -3.99% | 4.5分 |
| 58 | 乐心股份 | -5.42% | -11.79% | 4.1分 |
| 60 | 九强生物 | -5.70% | -4.50% | 4.6分 |
| 62 | 亚辉龙 | -5.83% | -5.74% | 4.8分 |
| 64 | 睿昂基因 | -6.15% | -5.23% | 4.8分 |
| 66 | 三友医疗 | -6.84% | -6.50% | 4.9分 |
| 68 | 拱东医疗 | -6.95% | -5.80% | 5.4分 |
| 70 | 天益医疗 | -7.30% | -6.07% | 5.0分 |
| 72 | 迈克生物 | -7.33% | -2.92% | 4.7分 |
| 74 | 三诺生物 | -7.44% | -5.18% | 5.1分 |
| 76 | 健帆生物 | -7.65% | -3.79% | 4.5分 |
| 78 | 瑞迈特 | -8.07% | -5.85% | 4.5分 |
| 80 | 东方生物 | -8.23% | -4.70% | 4.1分 |
| 82 | - | -8.68% | -8.95% | 分 |
| 84 | 康泰医学 | -8.98% | -5.17% | 4.1分 |
| 86 | 威高血净 | -9.09% | -1.75% | 5.5分 |
| 88 | 理邦仪器 | -9.40% | -5.17% | 4.8分 |
| 90 | 西山科技 | -9.73% | -5.00% | 3.7分 |
| 92 | 东星医疗 | -9.98% | -5.30% | 4.3分 |
| 94 | 万东医疗 | -10.11% | -5.97% | 4.2分 |
| 96 | 心脉医疗 | -10.47% | -4.52% | 4.8分 |
| 98 | 春立医疗 | -10.81% | -5.85% | 4.9分 |
| 100 | 祥生医疗 | -10.86% | -5.24% | 4.8分 |
| 102 | 戴维医疗 | -11.16% | -5.38% | 4.7分 |
| 104 | 爱博医疗 | -11.65% | -4.53% | 5.3分 |
| 106 | 凯普生物 | -12.01% | -4.41% | 4.2分 |
| 108 | - | -12.14% | -7.21% | 分 |
| 110 | 万泰生物 | -12.69% | -5.02% | 4.6分 |
| 112 | 乐普医疗 | -13.13% | -4.77% | 5.0分 |
| 114 | 济民健康 | -13.27% | -3.35% | 4.5分 |
| 116 | 大博医疗 | -13.71% | -6.11% | 4.7分 |
| 118 | 艾德生物 | -14.59% | -2.63% | 4.8分 |
| 120 | 天臣医疗 | -14.84% | -9.23% | 5.0分 |
| 122 | 麦澜德 | -15.91% | -7.18% | 4.0分 |
| 124 | 佰仁医疗 | -17.16% | -4.55% | 4.9分 |
| 126 | 硕世生物 | -17.60% | -8.35% | 4.2分 |
| 128 | 康众科技 | -18.42% | -3.00% | 4.5分 |
| 130 | 华大智造 | -18.93% | -6.28% | 4.8分 |
| 132 | 伟思医疗 | -19.44% | -8.58% | 5.4分 |
| 134 | 英诺特 | -20.23% | -6.46% | 4.4分 |
| 136 | 超研股份 | -21.01% | -6.69% | 4.6分 |
| 138 | 宝莱特 | -26.68% | -7.07% | 4.6分 |
| 140 | 华兰股份 | -27.51% | -6.36% | 4.6分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2026-06-30 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 90/244 ， 80/244。
[{"date":"2026-06-30","value":"0.83","vol":"2.35"},{"date":"2026-03-31","value":"-0.07","vol":"1.12"},{"date":"2025-12-31","value":"-3.33","vol":"2.37"},{"date":"2025-09-30","value":"-3.21","vol":"3.06"},{"date":"2025-06-30","value":"-2.24","vol":"2.40"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.83 | -0.07 | -3.33 | -3.21 | -2.24 |
| 行业(%) | 2.35 | 1.12 | 2.37 | 3.06 | 2.40 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"47.34","vol":"52.38"},{"date":"2026-03-31","value":"43.66","vol":"52.12"},{"date":"2025-12-31","value":"45.47","vol":"51.82"},{"date":"2025-09-30","value":"47.56","vol":"52.03"},{"date":"2025-06-30","value":"46.98","vol":"52.36"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
47.34 | 43.66 | 45.47 | 47.56 | 46.98 |
| 行业(%) | 52.38 | 52.12 | 51.82 | 52.03 | 52.36 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 98/244 ， 11/244。
[{"date":"2026-06-30","value":"-4.74","vol":"5.46"},{"date":"2026-03-31","value":"-6.14","vol":"5.59"},{"date":"2025-12-31","value":"-17.89","vol":"1.01"},{"date":"2025-09-30","value":"-20.38","vol":"0.11"},{"date":"2025-06-30","value":"-22.96","vol":"-1.37"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-4.74 | -6.14 | -17.89 | -20.38 | -22.96 |
| 行业(%) | 5.46 | 5.59 | 1.01 | 0.11 | -1.37 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"134.89","vol":"-24.55"},{"date":"2026-03-31","value":"89.76","vol":"-20.93"},{"date":"2025-12-31","value":"80.01","vol":"-33.44"},{"date":"2025-09-30","value":"51.25","vol":"-15.21"},{"date":"2025-06-30","value":"-16.46","vol":"-17.88"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
134.89 | 89.76 | 80.01 | 51.25 | -16.46 |
| 行业(%) | -24.55 | -20.93 | -33.44 | -15.21 | -17.88 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 116/244 ， 6/244。
[{"date":"2026-06-30","value":"0.07","vol":"0.17"},{"date":"2026-03-31","value":"0.03","vol":"0.08"},{"date":"2025-12-31","value":"0.15","vol":"0.35"},{"date":"2025-09-30","value":"0.11","vol":"0.25"},{"date":"2025-06-30","value":"0.07","vol":"0.17"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.07 | 0.03 | 0.15 | 0.11 | 0.07 |
| 行业(次) | 0.17 | 0.08 | 0.35 | 0.25 | 0.17 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"2.44","vol":"1.12"},{"date":"2026-03-31","value":"1.07","vol":"0.55"},{"date":"2025-12-31","value":"5.73","vol":"2.33"},{"date":"2025-09-30","value":"3.51","vol":"1.66"},{"date":"2025-06-30","value":"2.33","vol":"1.12"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.44 | 1.07 | 5.73 | 3.51 | 2.33 |
| 行业(次) | 1.12 | 0.55 | 2.33 | 1.66 | 1.12 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 39/244 ， 72/244。
[{"date":"2026-06-30","value":"26.26","vol":"14.81"},{"date":"2026-03-31","value":"19.83","vol":"-0.33"},{"date":"2025-12-31","value":"119.93","vol":"32.14"},{"date":"2025-09-30","value":"38.51","vol":"14.86"},{"date":"2025-06-30","value":"4.69","vol":"15.69"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 26.26 | 19.83 | 119.93 | 38.51 | 4.69 |
| 行业 | 14.81 | -0.33 | 32.14 | 14.86 | 15.69 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"1.13","vol":"1.31"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.52","vol":"1.62"},{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.36","vol":"1.58"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 1.13 | - | 0.52 | - | 0.36 |
| 行业 | 1.31 | 0.00 | 1.62 | 0.01 | 1.58 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 84/244 ， 90/244。
[{"date":"2026-06-30","value":"5.39","vol":"5.78"},{"date":"2026-03-31","value":"5.30","vol":"6.17"},{"date":"2025-12-31","value":"5.38","vol":"5.27"},{"date":"2025-09-30","value":"5.06","vol":"5.64"},{"date":"2025-06-30","value":"4.99","vol":"5.45"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
5.39 | 5.30 | 5.38 | 5.06 | 4.99 |
| 行业 | 5.78 | 6.17 | 5.27 | 5.64 | 5.45 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"4.91","vol":"4.71"},{"date":"2026-03-31","value":"4.85","vol":"5.04"},{"date":"2025-12-31","value":"4.98","vol":"4.13"},{"date":"2025-09-30","value":"4.65","vol":"4.49"},{"date":"2025-06-30","value":"4.59","vol":"4.34"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
4.91 | 4.85 | 4.98 | 4.65 | 4.59 |
| 行业 | 4.71 | 5.04 | 4.13 | 4.49 | 4.34 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 101/244 ， 103/244。
[{"date":"2026-06-30","value":"11.32","vol":"23.17"},{"date":"2026-03-31","value":"11.93","vol":"22.26"},{"date":"2025-12-31","value":"11.71","vol":"23.19"},{"date":"2025-09-30","value":"12.93","vol":"22.23"},{"date":"2025-06-30","value":"13.28","vol":"22.18"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
11.32 | 11.93 | 11.71 | 12.93 | 13.28 |
| 行业(%) | 23.17 | 22.26 | 23.19 | 22.23 | 22.18 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.12","vol":"0.42"},{"date":"2026-03-31","value":"0.13","vol":"0.40"},{"date":"2025-12-31","value":"0.13","vol":"0.41"},{"date":"2025-09-30","value":"0.14","vol":"0.72"},{"date":"2025-06-30","value":"0.15","vol":"0.58"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.12 | 0.13 | 0.13 | 0.14 | 0.15 |
| 行业(%) | 0.42 | 0.40 | 0.41 | 0.72 | 0.58 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"17.26","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.40","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-6.55","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-1.31","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]